• On The Pen: The Weekly Dose 4/30/24

  • Apr 30 2024
  • Length: 16 mins
  • Podcast

On The Pen: The Weekly Dose 4/30/24  By  cover art

On The Pen: The Weekly Dose 4/30/24

  • Summary

  • Send us a Text Message.

    1.7 mg of Wegovy is no longer in shortage:
    Semaglutide: FDA website updated to show 1.7 mg of Wegovy is no longer in shortage
    Link: https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Semaglutide%20Injection&st=c

    GNC introduces special section for GLP-1 users:
    GNC will have special section for GLP-1 users that will concentrate on four areas: GI Health, Retaining Lean muscle mass, Bone health, Nutritional support
    Link: https://www.gnc.com/learn/newsroom/gnc-semaglutide-support-program.html

    Identified upper dose values in tirzepatide high-dose trial
    20 mg and 25 mg
    Primary Completion in this trial is 12/24/2024 (Merry Christmas) with final completion September 30, 2025
    Link: https://www.onthepen.com/post/higher-doses-of-zepbound-and-mounjaro-being-tested

    US Senator Bernie Sanders investigating the price of Wegovy/Ozempic
    Ozempic costs $936 per month, while Wegovy costs $1,350
    Ozempic costs $155 in Canada, and cost $59 in Germany. This dramatic difference in cost has led to concerns about the accessibility and affordability of these drugs for American patients.
    With the cardiovascular disease indication, millions of additional medicare patients are eligible for taking Wegovy which means billions at the current prices
    Link: https://www.onthepen.com/post/the-price-of-health-bernie-sanders-investigates-ozempic-and-wegovy
    Link: https://www.kff.org/medicare/issue-brief/a-new-use-for-wegovy-opens-the-door-to-medicare-coverage-for-millions-of-people-with-obesity/

    Germany is promoting their pharmaceuticals industry:
    tax breaks, and speeding up clinical trials
    Eli Lilly is investing 2.3 Billion Euros to build a glp-1 manufacturing plant in Germany:
    Link: https://uk.finance.yahoo.com/news/scholz-promises-support-pharma-sector-101833297.html

    Lexaria begins phase 1 trial:
    Lexaria (stock symbol: LEXX) will test their technology to improve stomach absorption of Rybelsus in phase 1 trial (i.e. wouldn't need large 25/50 mg doses if absorption was better).
    They are also testing under tongue (sublingual) absorption of Rybelsus in another phase 1 trial
    Link: https://ir.lexariabioscience.com/news-events/press-releases/deta

    Support the Show.

    MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    BECOME A MEMBER HERE:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    SOCIAL LINKS
    https://www.tiktok.com/@manonthemounjaro
    https://twitter.com/ManOnMounjaro
    https://instagram.com/manonthemounjaro
    https://facebook.com/manonthemounjaro

    #Zepbound #releasethevials #mounjaro

    📲 Contact Me: MounjaroMan@gmail.com

    📼 PLAYLISTS:
    🖊️ ON THE PEN LIVES:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVdrWruYSrJpTZPF7jjXKfM
    👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
    https://www.youtube.com/watch?v=aplFxNOv77g&list=PLtOcNl0C8quWo7PWY9j_HilhWIRuedyiO
    😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quW-YZuu_DSpt_NS9fVQbMoW
    🚨📰 ALL THE LATEST MOUNJARO NEWS:
    https://www.youtube.com/playlist?list=PLtOcNl0C8quVo0I2YODK-q7cHh4y1r2yB

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.

    Show more Show less
activate_primeday_promo_in_buybox_DT

What listeners say about On The Pen: The Weekly Dose 4/30/24

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.